TIME AND DOSE-RELATED EFFECTS ON THE LIPID PROFILE IN HYPERLIPIDEMIA PATIENTS FOLLOWING TRIPLE COMBINATION THERAPY WITH EZETIMIBE/SIMVASTATIN + NIACIN
Publication
, Journal Article
Brown, BG; Fazio, S; Guyton, JR; Polis, A; Tomassini, JE; Tershakovec, AM
Published in: Atherosclerosis Supplements
May 2008
Duke Scholars
Published In
Atherosclerosis Supplements
DOI
ISSN
1567-5688
Publication Date
May 2008
Volume
9
Issue
1
Start / End Page
186 / 187
Publisher
Elsevier BV
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Brown, B. G., Fazio, S., Guyton, J. R., Polis, A., Tomassini, J. E., & Tershakovec, A. M. (2008). TIME AND DOSE-RELATED EFFECTS ON THE LIPID PROFILE IN HYPERLIPIDEMIA PATIENTS FOLLOWING TRIPLE COMBINATION THERAPY WITH EZETIMIBE/SIMVASTATIN + NIACIN. Atherosclerosis Supplements, 9(1), 186–187. https://doi.org/10.1016/s1567-5688(08)70749-9
Brown, B. G., S. Fazio, J. R. Guyton, A. Polis, J. E. Tomassini, and A. M. Tershakovec. “TIME AND DOSE-RELATED EFFECTS ON THE LIPID PROFILE IN HYPERLIPIDEMIA PATIENTS FOLLOWING TRIPLE COMBINATION THERAPY WITH EZETIMIBE/SIMVASTATIN + NIACIN.” Atherosclerosis Supplements 9, no. 1 (May 2008): 186–87. https://doi.org/10.1016/s1567-5688(08)70749-9.
Brown BG, Fazio S, Guyton JR, Polis A, Tomassini JE, Tershakovec AM. TIME AND DOSE-RELATED EFFECTS ON THE LIPID PROFILE IN HYPERLIPIDEMIA PATIENTS FOLLOWING TRIPLE COMBINATION THERAPY WITH EZETIMIBE/SIMVASTATIN + NIACIN. Atherosclerosis Supplements. 2008 May;9(1):186–7.
Brown, B. G., et al. “TIME AND DOSE-RELATED EFFECTS ON THE LIPID PROFILE IN HYPERLIPIDEMIA PATIENTS FOLLOWING TRIPLE COMBINATION THERAPY WITH EZETIMIBE/SIMVASTATIN + NIACIN.” Atherosclerosis Supplements, vol. 9, no. 1, Elsevier BV, May 2008, pp. 186–87. Crossref, doi:10.1016/s1567-5688(08)70749-9.
Brown BG, Fazio S, Guyton JR, Polis A, Tomassini JE, Tershakovec AM. TIME AND DOSE-RELATED EFFECTS ON THE LIPID PROFILE IN HYPERLIPIDEMIA PATIENTS FOLLOWING TRIPLE COMBINATION THERAPY WITH EZETIMIBE/SIMVASTATIN + NIACIN. Atherosclerosis Supplements. Elsevier BV; 2008 May;9(1):186–187.
Published In
Atherosclerosis Supplements
DOI
ISSN
1567-5688
Publication Date
May 2008
Volume
9
Issue
1
Start / End Page
186 / 187
Publisher
Elsevier BV
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology